News
TNFA
1.630
-4.68%
-0.080
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 6d ago
Weekly Report: what happened at TNFA last week (0826-0830)?
Weekly Report · 6d ago
Weekly Report: what happened at TNFA last week (0819-0823)?
Weekly Report · 08/26 12:27
TNF Pharmaceuticals Prepares To Advance MYMD-1, Targeting Age-Related Decline
Benzinga · 08/21 13:07
TNF PHARMACEUTICALS PREPARES TO ADVANCE LEAD CLINICAL PROGRAM TARGETING AGE-RELATED DECLINE
Reuters · 08/21 13:00
TNFA Stock Earnings: TNF Pharmaceuticals Reported Results for Q2 2024
Investorplace · 08/19 18:52
Based on the provided financial report articles, I generated the title for the article: "MYMD Technologies, Inc. (MYMD) Reports Financial Results for the Second Quarter Ended June 30, 2024" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content, I inferred the title to be related to MYMD Technologies' financial results for the second quarter of 2024.
Press release · 08/19 12:21
TNF Pharmaceuticals: Quarterly report
Press release · 08/19 12:13
Weekly Report: what happened at TNFA last week (0812-0816)?
Weekly Report · 08/19 12:08
TNF PHARMACEUTICALS: FILES FOR OFFERING OF 65.1 MLN SHARES OF COMMON STOCK - SEC FILING
Reuters · 08/12 21:21
Weekly Report: what happened at TNFA last week (0805-0809)?
Weekly Report · 08/12 12:11
Weekly Report: what happened at TNFA last week (0729-0802)?
Weekly Report · 08/05 12:26
Weekly Report: what happened at TNFA last week (0722-0726)?
Weekly Report · 07/29 12:12
*News On MyMD Pharmaceuticals Inc. (MYMD) Now Under TNFA
Dow Jones · 07/24 21:08
TNF Pharmaceuticals Trades Under New Ticker "TNFA"
Benzinga · 07/24 13:07
MyMD Pharma announces rebranding to TNF Pharmaceuticals
Seeking Alpha · 07/22 14:52
MYMD PHARMACEUTICALS ANNOUNCES CORPORATE REBRANDING TO NEW NAME TNF PHARMACEUTICALS, INC.
Reuters · 07/22 13:04
TNF PHARMACEUTICALS: COMMON STOCK, LISTED ON NASDAQ TO BEGIN TRADING UNDER NEW STOCK SYMBOL "TNFA," EFFECTIVE BEFORE MARKET OPEN ON WEDNESDAY, JULY 24
Reuters · 07/22 13:04
MyMD Pharmaceuticals Announces Corporate Rebranding To New Name TNF Pharmaceuticals, To Begin Under The New Trading Symbol "TNFA" Effective July 24, 2024
Benzinga · 07/22 13:02
Weekly Report: what happened at MYMD last week (0715-0719)?
Weekly Report · 07/22 12:13
More
Webull provides a variety of real-time TNFA stock news. You can receive the latest news about TNF Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About TNFA
TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. Supera-CBD is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the growing CBD market, which includes both Food and Drug Administration (FDA) approved drugs and CBD products not currently regulated as drugs.